Proteomic profiling reveals that ESR1 mutations enhance cyclin-dependent kinase signaling

Abstract Three quarters of all breast cancers express the estrogen receptor (ER, ESR1 gene), which promotes tumor growth and constitutes a direct target for endocrine therapies. ESR1 mutations have been implicated in therapy resistance in metastatic breast cancer, in particular to aromatase inhibito...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Tommaso De Marchi, Chun-Fui Lai, Georgia M. Simmons, Isabella Goldsbrough, Alison Harrod, Thai Lam, Lakjaya Buluwela, Sven Kjellström, Christian Brueffer, Lao H. Saal, Johan Malmström, Simak Ali, Emma Niméus
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	Nature Portfolio 2024-03-01
סדרה:	Scientific Reports
גישה מקוונת:	https://doi.org/10.1038/s41598-024-56412-8
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!